Granite Shares Advisors LLC Bio Techne Corp Transaction History

Granite Shares Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$65.98 - $77.09 $13,525 - $15,803	-205 Reduced 3.42%	5,792 $407,000
Q4 2023 Jan 30, 2024	SELL	$52.83 - $78.22 $5,811 - $8,604	-110 Reduced 1.8%	5,997 $462,000
Q3 2023 Oct 31, 2023	BUY	$67.52 - $89.42 $412,344 - $546,087	6,107 New	6,107 $415,000
Q1 2022 May 06, 2022	SELL	$353.85 - $487.79 $67,939 - $93,655	-192 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$456.15 - $525.06 $87,580 - $100,811	192 New	192 $99,000

598

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.97B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Shares Advisors LLC with notifications on news.